BDH Industries Ltd Q1 FY2027 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/as-2603c1c73e2f53c4a14e139f.pdf

Key Takeaways


Financial Performance


Growth Plan & New Unit

Suresh C. Kachara: "The answer is yes, BDH has growth plan and very soon in coming year we will be informing about the growth by way of setting up new unit or some."

R&D & Product Focus

Suresh C. Kachara: "We are into research and development but not the basic research. We do research on product development, product delivery, development etc. And our main focus is on oncology products and dermatology products."

Corporate Identity & Governance

Suresh C. Kachara: "As you know that we are in multiple business like pharma is main business but renewable energy and warehousing and the name has been decided at the time of incorporation to take care of different segments of industries. So the name represents BDH Industries very aptly."

Industry Environment


Outlook & Positioning

Yashree Nair: "We will continue to be a provider of high quality pharmaceutical products at economical rates and expect better future in the coming years."

Guidance & Commitments

CommitmentSpecificsTimeline
New unit announcementSetting up a new unit or similar growth initiative, details to be informed"Very soon in coming year"
Dividend declarationDividend on equity shares for FY ended 31 March 2026, subject to AGM approvalAGM resolution
Cost auditor ratificationRatify remuneration of cost auditors for FY2026-27AGM resolution

Key Metrics

MetricQ1 FY27
Revenue from operations₹95.95 crore for FY2025-26, up 44% from ₹66.50 crore in the previous year
Domestic sales₹45.93 crore for FY2025-26, compared to ₹35.55 crore in the previous year
Export sales₹50.02 crore for FY2025-26, compared to ₹30.96 crore in FY2024-25
Net profit₹10.81 crore for FY2025-26, compared to ₹9.27 crore in the previous year
Wind turbine capacity0.8 megawatt each, two turbines located at Jaisalmer, Rajasthan
DividendDeclared for the year ended 31st March 2026, as per ordinary resolution
Growth planNew unit or expansion to be announced in the coming year
R&D focusOncology and dermatology products, with work on product development and delivery